IP Verse

Angiopoietin-Like 3 (Angptl3) Irna Compositions And Methods Of Use Thereof

PatentPatent Analysis

EP3656860

ALNYLAM PHARMACEUTICALS
Application Number
EP19192281A
Filing Date
Jun 20, 2012
Status
Granted And Under Opposition
Mar 18, 2022
Grant Date
Apr 20, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3366775B1
EP3105331B1
EP2723758B1

Bibliography

The patent EP3656860B1 was granted to Alnylam Pharmaceuticals on Apr 20, 2022 following the initial filing on Jun 20, 2012 under the application number EP19192281A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GRUNECKER PATENT UND RECHTSANWALTE PARTG MBBJan 20, 2023ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents